Protein Kinase C β Inhibits Autophagy and Sensitizes Cervical Cancer Hela Cells to Cisplatin

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2017 Mar 2

PMID 28246354

Citations 7

Authors

Na Li

Wei Zhang

Affiliations

Soon will be listed here.

Abstract

Recently, autophagy has been indicated to play an essential role in various biological events, such as the response of cervical cancer cells to chemotherapy. However, the exact signalling mechanism that regulates autophagy during chemotherapy remains unclear. In the present study, we investigated the regulation by cisplatin on protein kinase C β (PKC β), on B-cell lymphoma 2 (Bcl-2) and on apoptosis in cervical cancer Hela cells. And then we examined the regulation by cisplatin on autophagy and the role of autophagy on the chemotherapy in Hela cells. In addition, the regulation of the PKC β on the autophagy was also investigated. Our results indicated that cisplatin promoted PKC β in Hela cells. The PKC β inhibitor reduced the cisplatin-induced apoptosis, whereas increased the cisplatin-induced autophagy in Hela cells. On the other side, the PKC β overexpression aggravated the cisplatin-induced apoptosis, whereas down-regulated the cisplatin-induced autophagy. Taken together, our study firstly recognized the involvement of PKC β in the cytotoxicity of cisplatin via inhibiting autophagy in cervical cancer cells. We propose that PKC β would sensitize cervical cancer cells to chemotherapy via reducing the chemotherapy induced autophagy in cancer cells.

Citing Articles

KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis.

Otero-Mateo M, Estrany Jr F, Arcas-Marquez S, Moya-Borrego L, Castellano G, Castany M Mol Ther Oncol. 2025; 33(1):200928.

PMID: 39877727 PMC: 11773232. DOI: 10.1016/j.omton.2024.200928.

Targeting Protein Kinase C for Cancer Therapy.

He S, Li Q, Huang Q, Cheng J Cancers (Basel). 2022; 14(5).

PMID: 35267413 PMC: 8909172. DOI: 10.3390/cancers14051104.

Selective Inhibition of PKC2 Restores Ischemic Postconditioning-Mediated Cardioprotection by Modulating Autophagy in Diabetic Rats.

Wang Y, Zhou L, Su W, Huang F, Zhang Y, Xia Z J Diabetes Res. 2020; 2020:2408240.

PMID: 32337288 PMC: 7157806. DOI: 10.1155/2020/2408240.

Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression.

Kaleli H, Ozer E, Kaya V, Kutlu O Cells. 2020; 9(3).

PMID: 32120776 PMC: 7140419. DOI: 10.3390/cells9030553.

Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy.

Wang Y, Chen Y, Chen X, Liang Y, Yang D, Dong J Exp Ther Med. 2019; 18(5):3365-3374.

PMID: 31602210 PMC: 6777310. DOI: 10.3892/etm.2019.7985.

References

Willey C, Xiao D, Tu T, Kim K, Moretti L, Niermann K . Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation. Int J Radiat Oncol Biol Phys. 2009; 77(5):1518-26. PMC: 3688843. DOI: 10.1016/j.ijrobp.2009.06.044. View

Wozniak K, Blasiak J . Recognition and repair of DNA-cisplatin adducts. Acta Biochim Pol. 2002; 49(3):583-96. View

Kouroedov A, Eto M, Joch H, Volpe M, Luscher T, Cosentino F . Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 2004; 110(1):91-6. DOI: 10.1161/01.CIR.0000133384.38551.A8. View

MacKay H, Twelves C . Targeting the protein kinase C family: are we there yet?. Nat Rev Cancer. 2007; 7(7):554-62. DOI: 10.1038/nrc2168. View

Lum J, Bauer D, Kong M, Harris M, Li C, Lindsten T . Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005; 120(2):237-48. DOI: 10.1016/j.cell.2004.11.046. View

Kaushal G, Kaushal V, Herzog C, Yang C . Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy. 2008; 4(5):710-2. DOI: 10.4161/auto.6309. View

Katayama M, Kawaguchi T, Berger M, Pieper R . DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2006; 14(3):548-58. DOI: 10.1038/sj.cdd.4402030. View

Burman C, Ktistakis N . Autophagosome formation in mammalian cells. Semin Immunopathol. 2010; 32(4):397-413. DOI: 10.1007/s00281-010-0222-z. View

Loehrer P, Einhorn L . Drugs five years later. Cisplatin. Ann Intern Med. 1984; 100(5):704-13. DOI: 10.7326/0003-4819-100-5-704. View

10.

Ma B, Liang L, Liao G, Liang Y, Liu H, Zheng G . Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands. J Oral Pathol Med. 2013; 42(10):774-80. DOI: 10.1111/jop.12066. View

11.

Teicher B, Alvarez E, Menon K, Esterman M, Considine E, Shih C . Antiangiogenic effects of a protein kinase Cbeta-selective small molecule. Cancer Chemother Pharmacol. 2002; 49(1):69-77. DOI: 10.1007/s00280-001-0386-2. View

12.

Takasaka N, Araya J, Hara H, Ito S, Kobayashi K, Kurita Y . Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. J Immunol. 2013; 192(3):958-68. DOI: 10.4049/jimmunol.1302341. View

13.

Seglen P, Gordon P . 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982; 79(6):1889-92. PMC: 346086. DOI: 10.1073/pnas.79.6.1889. View

14.

Ishii H, Jirousek M, Koya D, Takagi C, Xia P, Clermont A . Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996; 272(5262):728-31. DOI: 10.1126/science.272.5262.728. View

15.

Dasari S, Tchounwou P . Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014; 740:364-78. PMC: 4146684. DOI: 10.1016/j.ejphar.2014.07.025. View

16.

Basu A, Krishnamurthy S . Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids. 2010; 2010. PMC: 2929606. DOI: 10.4061/2010/201367. View

17.

Maioli E, Fortino V . Protein kinase C: a target for anticancer drugs?. Endocr Relat Cancer. 2004; 11(2):161-2. DOI: 10.1677/erc.0.0110161. View

18.

Reedijk J . New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. Proc Natl Acad Sci U S A. 2003; 100(7):3611-6. PMC: 152970. DOI: 10.1073/pnas.0737293100. View

19.

Carew J, Nawrocki S, Cleveland J . Modulating autophagy for therapeutic benefit. Autophagy. 2007; 3(5):464-7. DOI: 10.4161/auto.4311. View

20.

Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J . Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett. 2011; 314(2):232-43. DOI: 10.1016/j.canlet.2011.09.034. View